DERM - Company ID 0001867066
The table below shows Journey Medical Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $61.86M | $56.13M | $79.18M | $73.67M | $63.13M | $44.53M |
| Cost of revenue | $20.92M | $20.88M | $22.89M | $30.77M | $32.08M | $14.59M |
| Gross profit | - | - | - | - | - | - |
| R&D | $480.00K | $9.86M | $7.54M | $10.94M | $2.74M | - |
| SG&A |
Journey Medical Corp reported annual revenue of $61.86M for fiscal year 2025. That is up 10.2% from $56.13M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $44.53M (FY 2020) to $61.86M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $44.37M |
| $40.20M |
| $43.91M |
| $59.47M |
| $39.83M |
| $22.09M |
| Operating income | -$8.17M | -$13.68M | -$2.07M | -$27.52M | -$34.88M | $7.85M |
| Income tax | $60.00K | $61.00K | $221.00K | $63.00K | $1.63M | $1.87M |
| Net income | -$11.43M | -$14.67M | -$3.85M | -$29.63M | -$43.99M | $5.28M |
| EPS (diluted) | -$0.47 | -$0.72 | -$0.21 | -$1.69 | -$4.32 | $0.49 |